SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028124
Filing Date
2018-11-07
Accepted
2018-11-07 17:15:49
Documents
46
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcon-10q_20180930.htm 10-Q 1699755
2 EX-31.1 tcon-ex311_6.htm EX-31.1 9271
3 EX-32.1 tcon-ex321_7.htm EX-32.1 5376
  Complete submission text file 0001564590-18-028124.txt   6157279

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT tcon-20180930.xml EX-101.INS 1474014
5 XBRL TAXONOMY EXTENSION SCHEMA tcon-20180930.xsd EX-101.SCH 46417
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tcon-20180930_cal.xml EX-101.CAL 37057
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tcon-20180930_def.xml EX-101.DEF 138155
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcon-20180930_lab.xml EX-101.LAB 318303
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcon-20180930_pre.xml EX-101.PRE 231602
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36818 | Film No.: 181167359
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1